Videonadzor u poslovnoj i sudskoj praksi: zakonitost uvođenja, zaštita podataka i dopuštenost dokaza
Pulse of the norm · 20.07.2026 · 29
DOI: 10.66600/pn.2026.1.3.29 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pulse of the norm, online erschienen am 20.07.2026. Verfasst von Emina Bešlija und 1 weiteren Autor:innen.
Abstract (Originalsprache)
This paper analyzes the legal framework governing video surveillance at workplaces within Bosnia and Herzegovina, focusing on the prerequisites for its lawful implementation, procedural steps, data retention policies, and employee rights. The analysis is primarily based on the new Law on Personal Data Protection of 2025 (specifically Article 57), alongside the fundamental principles of legitimate interest, necessity, and proportionality, incorporating relevant administrative and judicial practice. Special emphasis is placed on the practical aspects of utilizing video recordings as evidence in criminal proceedings, as well as in civil and labor disputes. The objective of the paper is to highlight the legal modalities for balancing workplace security and the protection of employerproperty with the employees' right to privacy. The paper concludes that video surveillance remains a permissible measure only when implemented with absolute transparency, strict data minimization, and unwavering respect for employee dignity.
Zitieren
APA
Bešlija, E., & Trlin, D. (2026). Videonadzor u poslovnoj i sudskoj praksi: zakonitost uvođenja, zaštita podataka i dopuštenost dokaza. Pulse of the norm, 29. https://doi.org/10.66600/pn.2026.1.3.29
Vancouver
Bešlija E, Trlin D. Videonadzor u poslovnoj i sudskoj praksi: zakonitost uvođenja, zaštita podataka i dopuštenost dokaza. Pulse of the norm. 2026:29. doi:10.66600/pn.2026.1.3.29
BibTeX
@article{Belija2026,
author = {Bešlija, Emina and Trlin, Davor},
title = {Videonadzor u poslovnoj i sudskoj praksi: zakonitost uvođenja, zaštita podataka i dopuštenost dokaza},
journal = {Pulse of the norm},
year = {2026},
pages = {29},
doi = {10.66600/pn.2026.1.3.29}
}
EUVIMED